...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: What's the deal with Zenith?
3
Jun 21, 2023 04:54PM
3
Jun 22, 2023 07:41AM
6
Jun 22, 2023 02:26PM

And of course, this whole thing (as proposed by Don M.) is based on the premise that BOM2 will be a success so that Resverlogix will be able to pay its debt to Zenith and for Zenith C C to collect on the Resverlogix Royalty Preferred Shares.

Don sounded firm on this scenario, as a way of funding Resverlogix, BOM2 via Zenith et al. as if he can do it unilaterally without the approval of the Zenith Shareholders. 

 

Koo

3
Jun 23, 2023 01:54AM
1
Jun 23, 2023 02:15AM
3
Jun 23, 2023 10:24AM
5
Jun 24, 2023 08:49AM
Share
New Message
Please login to post a reply